It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

Each treatment cost under $10k per treatment.

Each treatment cost under $10k per treatment.

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

costs nothing to hold ladies.

however, Tesla is 3% with substantially less cost to borrow.

Buy and hold until you’re happy w your cost basis

Your cost is now lower as well 😂.

Cost down to $28.73… Will keep buying til I cant afford the stock price. lol

Got my cost down to $29.61.

Improved supply chain means lower costs and higher margins.

SSR + High Cost to Borrow + High FTDs due on 11th (over $1 million) + Trending = GOOD CHANCE FOR NICE PRICE POP💰💰💰 https://www.warriortrading.com/short-sale-restriction-ssr-fast-explanation/

$HKD Cost to borrow rapidly increasing now at 221% only 60K shares awailable, primed to run next week 🚀🚀🚀🚀🚀🚀🚀

$HKD had to take some $ on the run up and buy back lower - feeling pretty good now with a cost basis of 20$ - next run should be massive IMO 🫡

$HTGM primed for $10+: STRONG BUY signal 700K float 500%+ Cost to Borrow $3M MC w/ $14M in cash Recent analyst targets of $15.00+ Excellent technical setup Also watching: $WISA $SLRX $GNUS

🚨 $HTGM on Mega Watch 🚨 Innovative life science company with leading HTG platform (medicinal chemistry) tech: - 690K float - 900K outstanding - 550% Cost to Borrow (highest on market!)

$HTGM I love dollar cost averaging into a long term hold.

$HTGM shorts have been setup beautifully with 744 Cost to borrow 🤣🤣🤣🤣